Ann Arbor pharmaceutical company acquires nasal spray treatment manufacturer MLive.comEsperion Completes Corstasis Acquisition, Expands Cardiovascular Portfolio The Globe and MailEsperion Adds $25 Million Term Loans, Sells $50 Million Otsuka Royalties to Fund Corstasis Buy TradingViewEsperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) Yahoo FinanceEsperion completes acquisition of Corstasis Therapeutics Investing.com
